| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |